Clinical Pharmacokinetics of Slow-Acting Antirheumatic Drugs
- 1 November 1993
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 25 (5) , 392-407
- https://doi.org/10.2165/00003088-199325050-00005
Abstract
The pharmacokinetics of the slow acting antirheumatic drugs (SAARDs), hydroxychloroquine, chloroquine, penicillamine, the gold complexes and sulphasalazine, in humans have been studied. For all these...Keywords
This publication has 99 references indexed in Scilit:
- The Effect of Age and Acetylator Phenotype on the Pharmacokinetics of Sulfasalazine in Patients with Rheumatoid ArthritisClinical Pharmacokinetics, 1992
- Penicillamine in Rheumatoid ArthritisDrug Safety, 1992
- Clinical Pharmacokinetics of D-PenicillamineClinical Pharmacokinetics, 1987
- Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritisArthritis & Rheumatism, 1987
- Pharmacokinetics of chloroquine: Saliva and plasma levels relationshipEuropean Journal of Drug Metabolism and Pharmacokinetics, 1986
- Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic AcidClinical Pharmacokinetics, 1985
- Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis?New England Journal of Medicine, 1983
- A double‐blind trial of high versus conventional dosages of gold salts for rheumatoid arthritisArthritis & Rheumatism, 1977
- Monitoring Gold Plasma Levels in Rheumatoid ArthritisClinical Pharmacokinetics, 1977
- A multicentre1) controlled trial of the effects of different dosage of gold therapy, followed by a maintenance dosageInflammation Research, 1976